Vanda Pharmaceuticals, Inc. (VNDA)
7.07
+0.16
(+2.32%)
USD |
NASDAQ |
Apr 01, 16:00
7.07
0.00 (0.00%)
After-Hours: 05:20
Vanda Pharmaceuticals Research and Development Expense (TTM) : 109.27M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Gilead Sciences, Inc. | 5.688B |
| Axsome Therapeutics, Inc. | 182.48M |
| Gossamer Bio, Inc. | 174.07M |
| Arcellx, Inc. | 157.61M |